News

Flu shots now available at all Rite Aid stores

BY Antoinette Alexander

CAMP HILL, Pa. — Rite Aid has announced that seasonal flu shots are now available at all Rite Aid pharmacies nationwide.

Customers can visit any of the more than 4,600 Rite Aid pharmacies to receive a flu shot, which are covered by most insurance plans including Medicare Part B, from a Rite Aid certified immunizing pharmacist, subject to state regulations.

"While it’s too early to tell what the 2013-2014 flu season will bring, it’s not too early to visit your Rite Aid pharmacist for a flu shot," stated Robert Thompson, Rite Aid EVP of pharmacy. "Getting a flu shot as soon as it is available remains the single best way to protect yourself and others against the flu, because the more people in a community who are immunized, the less chance of a widespread outbreak in that community."

To help employers shield their workforce from the flu, Rite Aid also has a team dedicated to planning and implementing onsite workplace flu clinics, staffed by certified immunizing Rite Aid pharmacists. Alternatively, the team can also develop a voucher program, in which employees would receive a flu shot voucher to use at any Rite Aid pharmacy. According to the Centers for Disease Control and Prevention, each year, flu costs businesses approximately $10.4 billion in direct costs for hospitalizations and outpatient visits for adults.

The CDC recommends that everyone 6 months and older get a flu shot as soon as it is available, since it takes about two weeks after vaccination for antibodies to develop in the body and provide protection against the flu. A flu shot is recommended every year because flu viruses are constantly changing. The flu vaccine is formulated each year in an attempt to match the circulating strains of flu virus. The 2013-2014 vaccine will protect against an influenza A H3N2 virus, an influenza B virus and the H1N1 virus that emerged in 2009.

While the CDC recommends flu shots for everyone over 6 months, certain groups of people are at greater risk for complications from the flu. These groups include: pregnant women, adults over 65, children under age 5, those with asthma and other chronic lung diseases, those with kidney and liver disorders, heart disease patients and those with compromised immune systems.


Are you a nurse practitioner or physician’s assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.

keyboard_arrow_downCOMMENTS

Leave a Reply

W.Coppleman says:
Aug-17-2013 08:20 am

That's very great.. because everywhere viral infection and flu running around.. cosmetics packaging

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

PBM RxAdvance taps former Rite Aid, CVS Caremark execs to expand management team

BY Antoinette Alexander

SOUTHBOROUGH, Mass. — PBM company RxAdvance has expanded its executive management team with the hiring of former CVS Caremark and Rite Aid executives.

Frank Shiraldi joins the company as EVP and chief pharmacy officer. Schiraldi is responsible for development, implementation and oversight of the PBM program across multiple business lines. Schiraldi most recently served as VP business informatics at BeneCard PBF. Before that, he served as VP at Xerox Audit & Compliance Solutions, where he oversaw a pharmacy auditing company and developed pharmacy-claims analytical tools and fraud detection methodology. He held positions with McKesson and Rite Aid, with responsibilities in third-party administration and management.

Serving as EVP and CMO is Christine Kyle. Kyle is responsible for overall sales and marketing activities for all lines of business of the company. She is also responsible for strategic business development and partnership development. Most recently, Kyle served as the vice president of sales for Sodexo, a global healthcare onsite service solutions company. Previously, she was VP of specialty pharmacy payer sales and account services for CVS Caremark where she was responsible for providing strategic direction to support the market development of existing clients and expand into new and competitive markets.

Prakash Tallabattula joins the company as EVP and chief technology officer. Tallabattula will oversee all technology operations, research and development, both onshore and offshore. Prior to joining RxAdvance, Tallabattula worked as a senior enterprise architect at Fannie Mae, where he was responsible for the organization’s technology roadmap. He was also a senior architect at Verizon, where he played a key technical role on Verizon Dialup/DSL/FIOS solutions.

RxAdvance was established by Ravi Ika, founder and executive chairman of Southborough-based ikaSystems until this past February. Leveraging a cloud-based technology platform, Ika is striving to bring a “game-changing” approach to the PBM industry. According to the company, the innovation will significantly reduce RxAdvance’s administrative costs and plan sponsor unit costs; optimize drug utilization/adherence; and improve collaboration and transparency between plan sponsors and RxAdvance for better health outcomes.


Are you a nurse practitioner or physician’s assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Actavis names chief accounting officer

BY Jason Owen

PARSIPPANY, N.J. — Actavis today announced that James D’Arecca has joined the company as chief accounting officer. He will be reporting to R. Todd Joyce, chief financial officer — global.

Mr. D’Arecca joins Actavis from Bausch & Lomb, where he served in a similar role to his new Actavis position. Prior to Bausch & Lomb, he worked for Merck & Co., where he served as executive director and business development controller. In this role, he was the primary liaison between the controller’s organization and the business development and corporate licensing functions. Prior to joining Merck, Mr. D’Arecca was executive director and assistant controller at Schering-Plough. He also spent 13 years with PricewaterhouseCoopers, with an industry focus on pharmaceuticals, medical devices and consumer products.

Mr. D’Arecca earned his MBA from Columbia University, his BS in accounting from Rutgers University and is a Certified Public Accountant.


Are you a nurse practitioner or physician’s assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?